Mitral valve surgery for mitral regurgitation caused by Libman-Sacks endocarditis: A report of four cases and a systematic review of the literature

Journal of Cardiothoracic Surgery

Volumn 5, Issue 1, 2010, Pages

  Bouma, Wobbe ^a   Klinkenberg, Theo J ^a   van der Horst, Iwan C C ^a   Wijdh den Hamer, Inez J ^a   Erasmus, Michiel E ^a   Bijl, Marc ^a   Suurmeijer, Albert J H ^a   Zijlstra, Felix ^a   Mariani, Massimo A ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANTIPHOSPHOLIPID SYNDROME; CASE REPORT; ECHOCARDIOGRAPHY; ECHOGRAPHY; FEMALE; HEART VALVE REPLACEMENT; HUMAN; MALE; MIDDLE AGED; MITRAL VALVE; MITRAL VALVE REGURGITATION; PATHOLOGY; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; ANTIPHOSPHOLIPID SYNDROME; ECHOCARDIOGRAPHY; FEMALE; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; MITRAL VALVE; MITRAL VALVE INSUFFICIENCY;

EID: 77952257266     PISSN: None     EISSN: 17498090     Source Type: Journal    
DOI: 10.1186/1749-8090-5-13     Document Type: Review

References (64)

1. Libman E, Sacks B. A hitherto undescribed form of valvular and mural endocarditis. Arch Intern Med 1924, 33:701-37.
2. Gross L. The cardiac lesions in Libman-Sacks disease with a consideration of its relationship to acute diffuse lupus erythematosus. Am J Pathol 1940, 16:375-407. 1965099, 19970511.
3. D'Alton JG, Preston DN, Bormanis J, Green MS, Kraag GR. Multiple transient ischemic attacks, lupus anticoagulant and verrucous endocarditis. Stroke 1985, 16:512-4.
4. Cervera R, Khamashta MA, Font J, Reyes PA, Vianna JL, López-Soto A, Amigo MC, Asherson RA, Azqueta M, Paré C, Vargas J, Romero A, Ingelmo M, Hughes GRV. High prevalence of significant heart valve lesions in patients with the "primary" antiphospholipid syndrome. Lupus 1991, 1:43-7. 10.1177/096120339100100108, 1845363.
5. Hojnik M, George J, Ziporen L, Shoenfeld Y. Heart valve involvement (Libman-Sacks endocarditis) in the antiphospholipid syndrome. Circulation 1996, 93:1579-87.
6. Doherty NE, Siegel RJ. Cardiovascular manifestations of systemic lupus eryhematosus. Am Heart J 1985, 110:1257-65. 10.1016/0002-8703(85)90023-7, 3907317.
7. Ansari A, Larson PH, Bates HD. Cardiovascular manifestations of systemic lupus erythematosus: current perspective. Prog Cardiovasc Dis 1985, 27:421-34. 10.1016/0033-0620(85)90003-9, 2860699.
8. Moyssakis I, Tektonidou MG, Vasilliou VA, Samarkos M, Votteas V, Moutsopoulos HM. Libman-Sacks endocarditis in systemic lupus erythematosus: prevalence, associations, and evolution. Am J Med 2007, 120:636-42. 10.1016/j.amjmed.2007.01.024, 17602939.
9. Roldan CA, Shively BK, Lau CC, Gurule FT, Smith EA, Crawford MH. Systemic lupus erythematosus valve disease by transesophageal echocardiography and the role of antiphospholipid antibodies. J Am Coll Cardiol 1992, 20:1127-34.
10. Roldan CA, Shively BK, Crawford MH. An echocardiographic study of valvular heart disease associated with systemic lupus erythematosus. N Engl J Med 1996, 335:1424-30. 10.1056/NEJM199611073351903, 8875919.
11. Hughes GR, Harris NN, Gharavi AE. The anticardiolipin syndrome. J Rheumatol 1986, 13:486-9.
12. Harris EN. A reassessment of the antiphospholipid syndrome. J Rheumatol 1990, 17:733-5.
13. Levine JS, Branch DW, Rauch J. The antiphospholipid syndrome. N Engl J Med 2002, 346:752-63. 10.1056/NEJMra002974, 11882732.
14. Wilson WA, Gharavi AE, Koike T, Lockshin MD, Branch DW, Piette JC, Brey R, Derksen R, Harris EN, Hughes GR, Triplett DA, Khamashta MA. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Artritis Rheum 1999, 42:1309-11.
15. Khamashta MA, Cervera R, Asherson RA, Font J, Gil A, Coltart DJ, Vázquez JJ, Paré C, Ingelmo M, Oliver J, Hughes GR. Association of antibodies against phospholipids with heart valve disease in systemic lupus erythematosus. Lancet 1990, 335:1541-4. 10.1016/0140-6736(90)91373-I, 1972484.
16. Takayama T, Teramura M, Sakai H, Tamaki S, Okabayashi T, Kawashima T, Yamamoto T, Horie M, Suzuki T, Asai T. Perforated mitral valve aneurysm associated with Libman-Sacks endocarditis. Inter Med 2008, 47:1605-8.
17. Chartash EK, Lans DM, Paget SA, Qamar T, Lockshin MD. Aortic insufficiency and mitral regurgitation in patients with systemic lupus erythematosus and the antiphospholipid syndrome. Am J Med 1989, 86:407-12. 10.1016/0002-9343(89)90337-9, 2929627.
18. Ford SE, Charrette EJ, Knight J, Pym J, Ford P. A possible role for antiphospholipid antibodies in acquired cardiac valve deformity. J Rheumatol 1990, 17:1499-503.
19. Ziporen L, Goldberg I, Arad M, Hojnik M, Ordi-Ros J, Afek A, Blank M, Sandbank Y, Vilardell-Tarres M, de Torres I, Weinberger A, Asherson RA, Kopolovic Y, Shoenfeld Y. Libman-Sacks endocarditis in the antiphospholipid syndrome: immunopathologic findings in deformed heart valves. Lupus 1996, 5:196-205. 10.1177/096120339600500306, 8803890.
20. Gleason CB, Stoddard MF, Wagner SG, Longaker RA, Pierangeli S, Harris EN. A comparison of cardiac valvular involvement in the primary antiphospholipid syndrome versus anticardiolipin-negative systemic lupus erythematosus. Am Heart J 1993, 125:1123-9. 10.1016/0002-8703(93)90124-R, 8465738.
21. Asherson RA, Cervera R. Antiphospholipid antibodies and the heart. Lessons and pitfalls for the cardiologist. Circulation 1991, 84:920-3.
22. Asopa S, Patel A, Khan OA, Sharma R, Ohri SK. Non-bacterial thrombotic endocarditis. Eur J Cardiothorac Surg 2007, 32:696-701. 10.1016/j.ejcts.2007.07.029, 17881239.
23. Mottram PM, Gelman JS. Mitral valve thrombus mimicking a primary tumor in the antiphospholipid syndrome. J Am Soc Echocardiogr 2002, 15:746-8. 10.1067/mje.2002.118914, 12094176.
24. Taguchi S, Hashimoto K, Sakamoto Y, Okuyama H, Ishii S. A case of mitral valve plasty for Libman-Sacks endocarditis mimicking a cardiac tumor. J Thorac Cardiovasc Surg 2006, 132:1465-7. 10.1016/j.jtcvs.2006.07.034, 17140979.
25. Appelbe AF, Olson D, Mixon R, Craver JM, Martin RP. Libman-Sacks endocarditis mimicking intracardiac tumor. Am J Cardiol 1991, 68:817-8. 10.1016/0002-9149(91)90666-9, 1892098.
26. Lee JL, Naguwa SM, Cheema GS, Gershwin ME. Revisiting Libman-Sacks endocarditis: a historical review and update. Clin Rev Allergy Immunol 2009, 36:126-30. 10.1007/s12016-008-8113-y, 19089657.
27. Lehman TJ, Palmeri ST, Hastings C, Klippel JH, Plotz PH. Bacterial endocarditis complicating systemic lupus erythematosus. J Rheumatol 1983, 10:655-8.
28. Li JS, Sexton DJ, Mick N, Nettles R, Fowler VG, Ryan T, Bashore T, Corey GR. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis 2000, 30:633-8. 10.1086/313753, 10770721.
29. Ménard GE. Establishing the diagnosis of Libman-Sacks endocarditis in systemic lupus erythematosus. J Gen Intern Med 2008, 23:883-6. 10.1007/s11606-008-0627-8, 2517866, 18421506.
30. Feigenbaum H, Armstrong WF, Ryan T. Feigenbaum's Echocardiography 2005, 375-81. Philadelphia: Lippincott Williams and Wilkins.
31. Klarich KW, Enriquez-Sarano M, Gura GM, Edwards WD, Tajik AJ, Seward JB. Papillary firboelastoma: echocardiographic characteristics for diagnosis and pathologic correlation. J Am Coll Cardiol 1997, 30:784-90. 10.1016/S0735-1097(97)00211-8, 9283541.
32. Roldan CA, Qualls CR, Sopko KS, Sibbitt WL. Transthoracic versus transesophageal echocardiography for detection of Libman-Sacks endocarditis: a randomized controlled study. J Rheumatol 2008, 35:224-9.
33. Morin AM, Boyer AS, Nataf P, Gandjbakhch I. Mitral insufficiency caused by systemic lupus erythematosus requiring valve replacement: three case reports and a review of the literature. Thorac Cardiovasc Surg 1996, 44:313-6. 10.1055/s-2007-1012045, 9021911.
34. Bulkey BH, Roberts WC. Systemic lupus erythematosus as a cause of severe mitral regurgitation. New problem in an old disease. Am J Cardiol 1975, 35:305-8. 10.1016/0002-9149(75)90018-1, 804240.
35. Hoffman R, Lethen H, Zunker U, Schöndube FA, Maurin N, Sieberth HG. Rapid appearance of severe mitral regurgitation under high-dosage corticosteroid therapy in a patient with systemic lupus erythematosus. Eur Heart J 1994, 15:138-9.
36. Gonzalez-Juanatey C, Gonzalez-Gay MA. Libman-Sacks endocarditis and primary antiphospholipid syndrome. J Heart Valve Dis 2005, 14:700-2.
37. Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJV, Ponikowski P, Poole-Wilson PA, Strömberg A, van Veldhuisen DJ, Atar D, Hoes AW, Keren A, Mebazaa A, Nieminen M, Priori SG, Swedberg K. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008. Eur Heart J 2008, 29:2388-442. 10.1093/eurheartj/ehn309, 18799522.
38. Yun KL, Miller DC. Mitral valve repair versus replacement. Cardiol Clin 1991, 9:315-27.
39. Gillinov AM, Cosgrove DM. Current status of mitral valve repair. Am Heart Hosp J 2003, 1:47-54. 10.1111/j.1541-9215.2003.02082.x, 15785176.
40. Kalangos A, Panos A, Sezerman O. Mitral valve repair in lupus valvulitis - report of a case and review of the literature. J Heart Valve Dis 1995, 4:202-7.
41. Chauvaud SM, Kalangos A, Berrebi AJ, Gaer AR, Acar C, Carpentier AF. Systemic lupus erythematosus valvulitis: mitral valve replacement with a homograft. Ann Thorac Surg 1995, 60:1803-5. 10.1016/0003-4975(95)00625-7, 8787490.
42. Hakim JP, Mehta A, Jain AC, Murray GF. Mitral valve replacement and repair. Report of 5 patients with systemic lupus erythematosus. Tex Heart Inst J 2001, 28:47-52. 101131, 11330742.
43. Kato Y, Isobe F, Sasaki Y, Kodera K, Kumano H, Nagamachi K. Mitral insufficiency associated with primary antiphospholipid syndrome and chronic renal failure. Jpn J Thorac Cardiovasc Surg 2001, 49:171-4. 10.1007/BF02913596, 11305057.
44. Schneider C, Bahlmann E, Antz M, Bauer R, Reimers J, Raut W, Busch C, Rathjen F, Moll R, Kuck KH. Images in cardiovascular medicine. Unusual manifestation of Libman-Sacks endocarditis in systemic lupus erythematosus. Circulation 2003, 107:e202-4. 10.1161/01.CIR.0000063926.32375.D3, 12796416.
45. Fernández-Dueñas J, López-Granados A, Mesa-Rubio D, Ariz-Cañete J, Gallo-Marín M, Concha-Ruiz M. Severe mitral regurgitation in Libman-Sacks endocarditis. Conservative surgery. Rev Esp Cardiol 2005, 58:1118-20. 10.1157/13078558, 16185623.
46. Gordon RJ, Weilbaecher D, Davy SM, Safi HJ, Quiñones MA, DeFelice CA, Zoghbi WA. Valvulitis involving a bioprosthetic valve in a patient with systematic lupus erythematosus. J Am Soc Echocardiogr 1996, 9:104-7. 10.1016/S0894-7317(96)90112-1, 8679231.
47. Da Silva AN, Ferreira LD, Monaco CG, Silva CE, Gil MA, Peixoto LB, Ortiz J. Intracardiac thrombus and mitral prosthesis dysfunction in systemic lupus erythematosus. A case report. Rev Port Cardiol 2003, 22:213-9.
48. Myerowitz PD, Michaelis LL, McIntosh CL. Mitral valve replacement for mitral regurgitation due to Libman-Sacks endocarditis. Report of a case. J Thorac Cardiovasc Surg 1974, 67:869-74.
49. Murray FT, Fuleihan DS, Cornwall CS, Pinals RS. Acute mitral regurgitation from ruptured chordae tendineae in systemic lupus erythematosus. J Rheumatol 1975, 2:454-9.
50. Paget SA, Bulkley BH, Grauer LE, Seningen R. Mitral valve disease of systemic lupus erythematosus. A cause of severe congestive heart failure reversed by valve replacement. Am J Med 1975, 59:134-9. 10.1016/0002-9343(75)90331-9, 1138546.
51. Kinney EL, Wynn J, Ward S, Babb JD, Wine-Shaffer C, Zelis R. Ruptured chordae tendineae. Its association with systemic lupus erythematosus. Arch Pathol Lab Med 1980, 104:595-6.
52. Rawsthorne L, Ptacin MJ, Choi H, Olinger GN, Bamrah VS. Lupus valvulitis necessitating double valve replacement. Arthritis Rheum 1981, 24:561-4. 10.1002/art.1780240319, 7213435.
53. Brennan FJ, Ford SE, Ford PM, Morrin PA, Burggraf GW, Salerno TA. Mitral regurgitation due to lupus endocarditis treated with valve replacement. Can Med Assoc J 1983, 129:584-7. 1875580, 6883260.
54. Rozman B, Radovanovic N, Zorc M, Vraspir-Porenta O, Cijan A, Zemva A. Mitral valve replacement for lupus valvulitis. Z Rheumatol 1986, 45:322-4.
55. Moynihan T, Hansen R, Troup P, Olinger G. Simultaneous aortic and mitral valve replacement for lupus endocarditis: report of a case and review of the literature. J Thorac Cardiovasc Surg 1988, 95:142-5.
56. Straaton KV, Chatham WW, Reveille JD, Koopman WJ, Smith SH. Clinically significant valvular heart disease in systemic lupus erythematosus. Am J Med 1988, 85:645-50. 10.1016/S0002-9343(88)80236-5, 3189368.
57. Ferraris VA, Hawksley VC, Rabinowitz M, Coyne CM, Sullivan TJ, Sprague MS. Double valve replacement for lupus valvulitis: report of a case and review of the literature. Tex Heart Inst J 1990, 17:56-60. 324902, 15227191.
58. Alvarez-Blanco A, Egurbide-Arberas MV, Aguirre-Errasti C. Severe valvular heart disease in a patient with primary antiphospholipid syndrome. Lupus 1994, 3:433-4.
59. Shahian DM, Labib SB, Schneebaum AB. Etiology and management of chronic valve disease in antiphospholipid antibody syndrome and systemic lupus erythematosus. J Card Surg 1995, 10:133-9.
60. East CJ, Clements F, Mathew J, Slaughter TF. Antiphospholipid syndrome and cardiac surgery: management of anticoagulation in two patients. Anesth Analg 2000, 90:1098-101. 10.1097/00000539-200005000-00017, 10781459.
61. Georghiou GP, Shapira Y, Drozd T, Erez E, Raanani E, Vidne BA, Sahar G. Double-valve Libman-Sacks endocarditis: an entity that demands special consideration. J Heart Valve Dis 2003, 12:797-801.
62. Bordin G, Boldorini R, Meroni PL. The two hit hypothesis in the antiphospholipid syndrome: acute ischaemic heart involvement after valvular replacement despite anticoagulation in a patient with secondary APS. Lupus 2003, 12:851-3. 10.1191/0961203303lu445cr, 14667102.
63. Berkun Y, Elami A, Meir K, Mevorach D, Naparstek Y. Increased morbidity and mortality in patients with antiphospholipid syndrome undergoing valve replacement surgery. J Thorac Cardiovasc Surg 2004, 127:414-20. 10.1016/j.jtcvs.2003.07.016, 14762349.
64. Einav E, Gitig A, Marinescu LM, Tanaka KE, Spevack DM. Valvulitis requiring triple valve surgery as an initial presentation of systemic lupus erythematosus. J Am Soc Echocardiogr 2007, 20:e1-3.